- Achillion Pharmaceuticals — Initial Public Offering of Common Stock — $59,512,500 — Counsel to Issuer
- Acme Packet — Initial Public Offering of Common Stock — $116,584,000 — Counsel to Underwriters
- Alexion Pharmaceuticals — Public Offering of Common Stock — $148,350,000 — Counsel to Underwriters
- Alnylam Pharmaceuticals — Public Offerings of Common Stock — $165,917,000 — Counsel to Issuer
- Altus Pharmaceuticals — Initial Public Offering of Common Stock — $120,750,000 — Counsel to Underwriters
- CapitalSource — Public Offering of Common Stock — $414,000,000 — Counsel to Underwriters
- Ciena — Public Offering of 0.25% Convertible Senior Notes due 2013 — $300,000,000 — Counsel to Underwriters
- CIGNA — Public Offering of 6.150% Senior Notes due 2036 — $250,000,000 — Counsel to Issuer
- CIT Group — Public Offerings of Medium-Term Notes — $16,350,216,000 — Counsel to Underwriters and Agents
- CollaGenex Pharmaceuticals — Public Offering of Common Stock — $45,500,000 — Counsel to Issuer
- Corporación Andina de Fomento — Public Offering of 5.75% Notes Due 2017 — $250,000,000 — Counsel to Underwriters
- CTC Media — Initial Public Offering of Common Stock — $380,525,000 — Counsel to Issuer
- Cubist Pharmaceuticals — Public Offering of 2.25% Convertible Subordinated Notes due 2013 — $350,000,000 — Counsel to Underwriters
- Dean Foods — Public Offering of 7.000% Senior Notes due 2016 — $500,000,000 — Counsel to Issuer
- Emergent BioSolutions — Initial Public Offering of Common Stock — $62,500,000 — Counsel to Issuer
- Evercore Partners — Initial Public Offering of Common Stock — $95,392,500 — Counsel to Underwriters
- Globalstar — Initial Public Offering of Common Stock — $146,625,000 — Regulatory Counsel to Issuer
- GTx — Public Offering of Common Stock — $60,793,600 — Counsel to Underwriters
- Labopharm — Initial Public Offering of Common Stock — $101,200,000 — Counsel to Underwriters
- LeMaitre Vascular — Initial Public Offering of Common Stock — $38,500,000 — Counsel to Underwriters
- MBB Industries — Initial Public Offering of Common Stock — €17,480,000 — Counsel to Issuer
- Medtronic — Rule 144A Placement of 1.50% Convertible Senior Notes due 2011 and 1.625% Convertible Senior Notes due 2013 — $4,400,000,000 — Counsel to Issuer
- Millennium Pharmaceuticals — Public Offering of 2.25% Convertible Senior Notes due 2011 — $250,000,000 — Counsel to Issuer
- NitroMed — Public Offering of Common Stock — $62,504,500 — Counsel to Issuer
- NxStage Medical — Public Offering of Common Stock — $56,336,000 — Counsel to Issuer
- Optos — Initial Public Offering of Ordinary Shares — £50,000,000 — Counsel to Issuer
- PS Business Parks — Public Offerings of Preferred Stock — $94,600,000 — Counsel to Underwriters
- SS&C Technologies — Exchange Offer for 11 3/4% Senior Subordinated Notes due 2013 — $205,000,000 — Counsel to Issuer
- Speedel — Public Offering of Common Stock — CHF 96,541,500 — Counsel to Issuer
- Targacept — Initial Public Offering of Common Stock — $45,000,000 — Counsel to Underwriters
- Temenos Group — Public Offering of 1.5% Convertible Bonds due 2013 — CHF 132,500,000 — Counsel to Issuer
- Visicu — Initial Public Offering of Common Stock — $110,400,000 — Counsel to Underwriters
- Watts Water Technologies — Public Offering of Common Stock — $230,000,000 — Counsel to Issuer
- World Energy Solutions — Initial Public Offering of Common Stock — $25,525,000 — Counsel to Issuer